A Synthetic Nanoparticle Based Vaccine Approach Targeting MSP4/5 Is Immunogenic and Induces Moderate Protection Against Murine Blood-Stage Malaria
Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2019.00331
Full Text
Open PDFAbstract
Available in full text
Date
March 15, 2019
Authors
Publisher
Frontiers Media SA